Home | Drugs Approvals and Trials

Drugs Approvals and Trials

Young adults needed for snacking and meal skipping study

Young adults are showing some of the highest rates of snacking and skipping meals - especially breakfast - and yet, until now, ...

Study finds opioid prescriptions down at Temple University Hospital

The implementation of a voluntary prescribing guideline aims to reduce addiction to and overdose from addictive painkillers. ...

ITM succesfully completes large European Ebola study

ITM succesfully completes large European Ebola study ... Full story

Pioneering Artificial Pancreas, Developed at UVA, to Undergo Final Tests

A device developed by University of Virginia School of Medicine researchers to automatically monitor and regulate blood-sugar levels in people with type 1 diabetes will undergo final testing in two clinical trials beginning early this year. ... Full story

FDA approves new orphan drug to treat pulmonary arterial hypertension

On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation. ... Full story

Not-for-profit startup aims to evaluate Purdue drug compounds before clinical trials

WEST LAFAYETTE, Ind. - Entrepreneurs have launched a nonprofit startup that will option Purdue University-discovered drug compounds and could shepherd them through proof-of-principle clinical trials. ... Full story

FDA approves first emergency treatment for overdose of certain types of chemotherapy

The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments. ... Full story

FDA approves first recombinant von Willebrand factor to treat bleeding episodes

The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). ... Full story

FDA approves first drug to treat a rare enzyme disorder in pediatric and adult patients

Today, the U.S. Food and Drug Administration approved Kanuma (sebelipase alfa) as the first treatment for patients with a rare disease known as lysosomal acid lipase (LAL) deficiency. ... Full story

FDA approves Opdivo to treat advanced form of kidney cancer

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 550 | displaying: 1 - 10